THERAVANCE INC's ticker is and the CUSIP is 88338TAB0. A total of 25 filers reported holding THERAVANCE INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2021 | $31,819,000 | -14.1% | 29,135,000 | -15.2% | 0.54% | -21.9% |
Q3 2021 | $37,048,000 | +0.5% | 34,364,000 | -4.7% | 0.68% | -4.5% |
Q2 2021 | $36,873,000 | +29.5% | 36,073,000 | +27.2% | 0.72% | +16.8% |
Q1 2021 | $28,480,000 | +33.5% | 28,350,000 | +33.1% | 0.61% | +34.9% |
Q4 2020 | $21,328,000 | -1.5% | 21,293,000 | -5.4% | 0.46% | -4.8% |
Q3 2020 | $21,647,000 | -8.5% | 22,500,000 | -5.5% | 0.48% | -13.7% |
Q2 2020 | $23,646,000 | -29.7% | 23,801,000 | -34.2% | 0.55% | -24.2% |
Q1 2020 | $33,613,000 | -6.5% | 36,159,000 | +1.7% | 0.73% | +5.0% |
Q4 2019 | $35,953,000 | +8.4% | 35,565,000 | +1.2% | 0.70% | +12.1% |
Q3 2019 | $33,156,000 | -10.0% | 35,150,000 | +0.3% | 0.62% | -12.9% |
Q2 2019 | $36,824,000 | +8.4% | 35,038,000 | +4.4% | 0.71% | -4.8% |
Q1 2019 | $33,962,000 | -8.9% | 33,576,000 | -2.3% | 0.75% | -16.9% |
Q4 2018 | $37,269,000 | -2.5% | 34,364,000 | -8.3% | 0.90% | +14.3% |
Q3 2018 | $38,239,000 | +204.7% | 37,486,000 | +188.4% | 0.79% | +198.5% |
Q2 2018 | $12,550,000 | +49.5% | 13,000,000 | +66.0% | 0.26% | +60.0% |
Q1 2018 | $8,394,000 | +30.0% | 7,829,000 | +20.4% | 0.16% | +33.1% |
Q4 2017 | $6,457,000 | +1.5% | 6,500,000 | 0.0% | 0.12% | +3.3% |
Q3 2017 | $6,359,000 | -32.0% | 6,500,000 | -36.6% | 0.12% | -33.0% |
Q2 2017 | $9,357,000 | -18.0% | 10,250,000 | -14.6% | 0.18% | -16.0% |
Q1 2017 | $11,410,000 | +106.2% | 12,000,000 | +84.6% | 0.21% | +108.8% |
Q4 2016 | $5,533,000 | -7.6% | 6,500,000 | -8.5% | 0.10% | +17.2% |
Q3 2016 | $5,985,000 | +4.9% | 7,100,000 | 0.0% | 0.09% | -1.1% |
Q2 2016 | $5,705,000 | +10.1% | 7,100,000 | +9.2% | 0.09% | +11.4% |
Q1 2016 | $5,180,000 | -40.5% | 6,500,000 | -42.6% | 0.08% | -41.0% |
Q4 2015 | $8,710,000 | -23.9% | 11,327,000 | -33.9% | 0.13% | -23.4% |
Q3 2015 | $11,447,000 | -58.6% | 17,131,000 | -41.2% | 0.18% | -56.0% |
Q2 2015 | $27,644,000 | +9.8% | 29,131,000 | -1.1% | 0.40% | +9.3% |
Q1 2015 | $25,167,000 | +41.1% | 29,453,000 | +29.8% | 0.36% | +38.9% |
Q4 2014 | $17,830,000 | -9.5% | 22,692,000 | +8.7% | 0.26% | -13.8% |
Q3 2014 | $19,706,000 | -10.1% | 20,876,000 | -6.2% | 0.30% | -7.0% |
Q2 2014 | $21,925,000 | -36.1% | 22,267,000 | -15.7% | 0.33% | -39.0% |
Q1 2014 | $34,312,000 | -17.2% | 26,409,000 | -7.1% | 0.54% | +2.9% |
Q4 2013 | $41,428,000 | +37.8% | 28,424,000 | +54.5% | 0.52% | +29.0% |
Q3 2013 | $30,062,000 | +31.2% | 18,398,000 | +23.9% | 0.40% | +12.2% |
Q2 2013 | $22,916,000 | – | 14,844,000 | – | 0.36% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
HUNTINGTON NATIONAL BANK | 1 | $1 | 0.00% |